According to a TechCrunch report, the cost of the Edition version of the newly-unveiled Apple Watch wearable tech device will likely be nearly $1,200.
The Apple Watch's Edition version - in 18 karat yellow or rose gold - will be one of the three versions of Apple's new wearable device. The other two options in the Watch will be the entry-level $345 standard version with a stainless steel case; and the Apple Watch Sport version in lightweight aluminum. All the three versions will be available in two sizes each.
The TechCrunch report's estimates about the cost of the Edition version of the Apple Watch are largely based on the projections made by "jewelers familiar with the material" used for making the smartwatch, in terms of its weight and size.
Going by the estimates of Chad Rickicki, a watch expert in Pittsburgh, Pennsylvania, the manufacturing cost of the case for the size and shape of the Apple Watch in 18 carat gold would be approximately $600. The electronics and markup for the device will apparently increase that price by two times.
Meanwhile, though Apple has not specifically mentioned on its website whether the case of the Edition version of the Watch will be solid gold or gold-plated, the company has, nonetheless, noted that the watch case is "crafted from 18-karat gold that our metallurgists have developed to be up to twice as hard as standard gold."
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).